These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8719443)

  • 21. Clinician and payer issues in managing growth hormone deficiency.
    Owens GM
    Am J Manag Care; 2000 Sep; 6(15 Suppl):S839-52; quiz S853-5. PubMed ID: 11184425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G; Izzo G; La Montagna G; Bellastella A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Justified and unjustified use of growth hormone.
    van der Lely AJ
    Postgrad Med J; 2004 Oct; 80(948):577-80. PubMed ID: 15466991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body proportions before and during growth hormone therapy in children with chronic renal failure.
    de Graaff LC; Mulder PG; Hokken-Koelega AC
    Pediatr Nephrol; 2003 Jul; 18(7):679-84. PubMed ID: 12734746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone therapy for short stature: panacea or Pandora's box?
    Allen DB; Fost NC
    J Pediatr; 1990 Jul; 117(1 Pt 1):16-21. PubMed ID: 2196357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone treatment in non-classical GH deficient children.
    Saggese G; Cesaretti G; Di Spigno G; Giannessi N; Bracaloni C; Cinquanta L; Cioni C
    J Endocrinol Invest; 1989; 12(8 Suppl 3):125-6. PubMed ID: 2809084
    [No Abstract]   [Full Text] [Related]  

  • 27. Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency.
    Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Dahlgren J
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):407-15. PubMed ID: 22417085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.
    Koranyi J; Svensson J; Götherström G; Sunnerhagen KS; Bengtsson B; Johannsson G
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4693-9. PubMed ID: 11600527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone deficiency and hyperthermia during exercise: a controlled study of sixteen GH-deficient patients.
    Juul A; Hjortskov N; Jepsen LT; Nielsen B; Halkjaer-Kristensen J; Vahl N; Jørgensen JO; Christiansen JS; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3335-40. PubMed ID: 7593447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laron syndrome: clinical features, molecular pathology and treatment.
    Laron Z; Klinger B
    Horm Res; 1994; 42(4-5):198-202. PubMed ID: 7868073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
    Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The response to treatment with pituitary growth hormone: the New Zealand experience.
    Livesey JH; Cuneo RC; Donald RA; Harris RG; Ibberston HK; Costello JM; Holdaway IM; Gluckman PD; Fraser TR; Chapman GE
    N Z Med J; 1989 Aug; 102(873):399-402. PubMed ID: 2761875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic controversies: growth hormone (GH) treatment of non-GH deficient subjects.
    Allen DB; Brook CG; Bridges NA; Hindmarsh PC; Guyda HJ; Frazier D
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1239-48. PubMed ID: 7962315
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy.
    Johansen JS; Jensen SB; Riis BJ; Rasmussen L; Zachmann M; Christiansen C
    J Clin Endocrinol Metab; 1990 Jul; 71(1):122-6. PubMed ID: 2370291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
    Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
    Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
    Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
    Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current developments in the treatment of growth delay using growth hormone].
    Wit JM
    Tijdschr Kindergeneeskd; 1986 Dec; 54(6):170-6. PubMed ID: 3103256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.
    de Boer H; Blok GJ; Voerman B; Derriks P; van der Veen E
    Int J Obes Relat Metab Disord; 1996 Jun; 20(6):580-7. PubMed ID: 8782736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.